Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
| NCT ID | NCT02420717 |
| Title | Ruxolitinib Phosphate or Dasatinib With Chemotherapy in Treating Patients With Relapsed or Refractory Philadelphia Chromosome-Like Acute Lymphoblastic Leukemia |
| Recruitment | Terminated |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | M.D. Anderson Cancer Center |
| Indications | |
| Therapies |
Cyclophosphamide + Dexamethasone + Doxorubicin + Vincristine Sulfate Mercaptopurine + Methotrexate + Prednisone + Vincristine Sulfate |
| Age Groups: | child | adult |
| Covered Countries | USA |